Alteration of glutamate receptors in the striatum of dyskinetic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys following dopamine agonist treatment-Reference-Cited by-同舟云学术

Alteration of glutamate receptors in the striatum of dyskinetic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys following dopamine agonist treatment

Published:2002-01 Issue:1 Volume:26 Page:127-138
ISSN:0278-5846
Container-title:Progress in Neuro-Psychopharmacology and Biological Psychiatry
language:en
Short-container-title:Progress in Neuro-Psychopharmacology and Biological Psychiatry

Author:

Calon Frédéric,Morissette Marc,Ghribi Othman,Goulet Martin,Grondin Richard,Blanchet Pierre J,Bédard Paul J,DiPaolo Thérèse

Publisher

Elsevier BV

Subject

Biological Psychiatry,Pharmacology

Reference86 articles.

1. Excitatory amino acid binding sites in the basal ganglia of the rat: a quantitative autoradiographic study;Albin;Neuroscience,1992

2. Cloning and analysis of the 5′ flanking sequence of the rat N-methyl-d-aspartate receptor 1 (NMDAR1) gene;Bai;Biochem. Biophys. Acta,1993

3. The distribution of excitatory amino acid receptors in the normal human midbrain and basal ganglia with implications for Parkinson's disease: a quantitative autoradiographic study using [3H]MK-801, [3H]glycine, [3H]CNQX and [3H]kainate;Ball;Brain Res.,1994

4. Role of selective D1 and D2 agonists in inducing dyskinesia in drug-naive MPTP monkeys;Bedard;Adv. Neurol.,1993

5. Dopamine receptor families and the treatment of Parkinson's disease;Bedard;Clin. Neuropharmacol.,1995

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cell- and state-specific plasticity of striatal glutamatergic synapses is critical to the expression of levodopa-induced dyskinesia;2024-06-14

2. The neuroprotective potential of magnesium in Parkinson’s disease;Magnesium Research;2024-06

3. Targeting Striatal Glutamate and Phosphodiesterases to Control L-DOPA-Induced Dyskinesia;Cells;2023-11-30

4. Molecular mechanisms underlying the neuroprotection of environmental enrichment in Parkinson’s disease;Neural Regeneration Research;2023

5. Glutamate modulation for the treatment of levodopa induced dyskinesia: a brief review of the drugs tested in the clinic;Neurodegenerative Disease Management;2022-08